ALiBERO: Evolving a Team of Complementary Pocket Conformations Rather than a Single Leader
暂无分享,去创建一个
[1] Ruben Abagyan,et al. A new method for ligand docking to flexible receptors by dual alanine scanning and refinement (SCARE) , 2008, J. Comput. Aided Mol. Des..
[2] Ruben Abagyan,et al. Structure based prediction of subtype-selectivity for adenosine receptor antagonists , 2011, Neuropharmacology.
[3] Heather A Carlson,et al. Exploring experimental sources of multiple protein conformations in structure-based drug design. , 2007, Journal of the American Chemical Society.
[4] Jozef Hritz,et al. Impact of plasticity and flexibility on docking results for cytochrome P450 2D6: a combined approach of molecular dynamics and ligand docking. , 2008, Journal of medicinal chemistry.
[5] Ruben Abagyan,et al. Structure-Based Discovery of Novel Chemotypes for Adenosine A 2 A Receptor Antagonists , 2010 .
[6] Eric T. Kim,et al. How does a drug molecule find its target binding site? , 2011, Journal of the American Chemical Society.
[7] R Abagyan,et al. Discovery of antiandrogen activity of nonsteroidal scaffolds of marketed drugs , 2007, Proceedings of the National Academy of Sciences.
[8] R. Abagyan,et al. Flexible ligand docking to multiple receptor conformations: a practical alternative. , 2008, Current opinion in structural biology.
[9] William L. Jorgensen,et al. Journal of Chemical Information and Modeling , 2005, J. Chem. Inf. Model..
[10] X. Zou,et al. Ensemble docking of multiple protein structures: Considering protein structural variations in molecular docking , 2006, Proteins.
[11] Ruben Abagyan,et al. Structure-based discovery of novel chemotypes for adenosine A(2A) receptor antagonists. , 2010, Journal of medicinal chemistry.
[12] Ruben Abagyan,et al. Ligand-guided receptor optimization. , 2012, Methods in molecular biology.
[13] Sérgio Simões,et al. Ligand-guided optimization of CXCR4 homology models for virtual screening using a multiple chemotype approach , 2010, J. Comput. Aided Mol. Des..
[14] Somesh D. Sharma,et al. Managing protein flexibility in docking and its applications. , 2009, Drug discovery today.
[15] Ruben Abagyan,et al. Pocketome: an encyclopedia of small-molecule binding sites in 4D , 2011, Nucleic Acids Res..
[16] Pedro Alexandrino Fernandes,et al. Protein–ligand docking: Current status and future challenges , 2006, Proteins.
[17] Marcel L. Verdonk,et al. Protein-Ligand Docking against Non-Native Protein Conformers , 2008, J. Chem. Inf. Model..
[18] Ruben Abagyan,et al. SimiCon: a web tool for protein-ligand model comparison through calculation of equivalent atomic contacts , 2010, Bioinform..
[19] Oliver Korb,et al. Potential and Limitations of Ensemble Docking , 2012, J. Chem. Inf. Model..
[20] Ruben Abagyan,et al. Analysis of full and partial agonists binding to β2‐adrenergic receptor suggests a role of transmembrane helix V in agonist‐specific conformational changes , 2009, Journal of molecular recognition : JMR.
[21] M L Teodoro,et al. Conformational flexibility models for the receptor in structure based drug design. , 2003, Current pharmaceutical design.
[22] S. Moro,et al. Pyrazolo-triazolo-pyrimidines as adenosine receptor antagonists: Effect of the N-5 bond type on the affinity and selectivity at the four adenosine receptor subtypes , 2007, Purinergic Signalling.
[23] R. Abagyan,et al. GPCR 3 D homology models for ligand screening : Lessons learned from blind predictions of adenosine A 2 a receptor complex , 2009 .
[24] M. Karplus,et al. Molecular dynamics and protein function. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[25] R. Abagyan,et al. Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins. , 1994, Journal of molecular biology.
[26] Maxim Totrov,et al. Ligand binding site superposition and comparison based on Atomic Property Fields: identification of distant homologues, convergent evolution and PDB-wide clustering of binding sites , 2011, BMC Bioinformatics.
[27] Claudio N. Cavasotto,et al. Discovery of novel chemotypes to a G-protein-coupled receptor through ligand-steered homology modeling and structure-based virtual screening. , 2008, Journal of medicinal chemistry.
[28] Yan Li,et al. Discovery of Novel Checkpoint Kinase 1 Inhibitors by Virtual Screening Based on Multiple Crystal Structures , 2011, J. Chem. Inf. Model..
[29] Ruben Abagyan,et al. Recipes for the Selection of Experimental Protein Conformations for Virtual Screening , 2010, J. Chem. Inf. Model..
[30] John P. Overington,et al. ChEMBL: a large-scale bioactivity database for drug discovery , 2011, Nucleic Acids Res..
[31] R. Abagyan,et al. Pocketome via Comprehensive Identification and Classification of Ligand Binding Envelopes* , 2005, Molecular & Cellular Proteomics.
[32] Ruben Abagyan,et al. Four-dimensional docking: a fast and accurate account of discrete receptor flexibility in ligand docking. , 2009, Journal of medicinal chemistry.
[33] J. Irwin,et al. Benchmarking sets for molecular docking. , 2006, Journal of medicinal chemistry.
[34] S. Teague. Implications of protein flexibility for drug discovery , 2003, Nature Reviews Drug Discovery.
[35] Ruben Abagyan,et al. Prediction of the binding energy for small molecules, peptides and proteins , 1999, Journal of molecular recognition : JMR.
[36] R Abagyan,et al. Homology modeling by the ICM method , 1995, Proteins.
[37] Ruben Abagyan,et al. GPCR 3D homology models for ligand screening: Lessons learned from blind predictions of adenosine A2a receptor complex , 2010, Proteins.
[38] Claudio N. Cavasotto,et al. Protein flexibility in ligand docking and virtual screening to protein kinases. , 2004, Journal of molecular biology.
[39] X. Barril,et al. Unveiling the full potential of flexible receptor docking using multiple crystallographic structures. , 2005, Journal of medicinal chemistry.
[40] H. Scheraga,et al. Energy parameters in polypeptides. 10. Improved geometrical parameters and nonbonded interactions for use in the ECEPP/3 algorithm, with application to proline-containing peptides , 1994 .
[41] Claudio N. Cavasotto,et al. Representing receptor flexibility in ligand docking through relevant normal modes. , 2005, Journal of the American Chemical Society.
[42] Adrian H Elcock,et al. Structure selection for protein kinase docking and virtual screening: homology models or crystal structures? , 2006, Current protein & peptide science.
[43] Albert C. Pan,et al. Pathway and mechanism of drug binding to G-protein-coupled receptors , 2011, Proceedings of the National Academy of Sciences.
[44] T. Halgren. Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94 , 1996, J. Comput. Chem..
[45] Rommie E. Amaro,et al. An improved relaxed complex scheme for receptor flexibility in computer-aided drug design , 2008, J. Comput. Aided Mol. Des..
[46] J Andrew McCammon,et al. Target flexibility in molecular recognition. , 2005, Biochimica et biophysica acta.
[47] Ruben Abagyan,et al. Docking and scoring with ICM: the benchmarking results and strategies for improvement , 2012, Journal of Computer-Aided Molecular Design.
[48] Ruben Abagyan,et al. Consistent Improvement of Cross-Docking Results Using Binding Site Ensembles Generated with Elastic Network Normal Modes , 2009, J. Chem. Inf. Model..
[49] R Abagyan,et al. Flexible protein–ligand docking by global energy optimization in internal coordinates , 1997, Proteins.
[50] James Andrew McCammon,et al. Predictive Power of Molecular Dynamics Receptor Structures in Virtual Screening , 2011, J. Chem. Inf. Model..
[51] Jonathan W. Essex,et al. Ensemble Docking into Multiple Crystallographically Derived Protein Structures: An Evaluation Based on the Statistical Analysis of Enrichments , 2010, J. Chem. Inf. Model..
[52] J A McCammon,et al. Accommodating protein flexibility in computational drug design. , 2000, Molecular pharmacology.
[53] Reiji Teramoto,et al. Supervised Consensus Scoring for Docking and Virtual Screening , 2007, J. Chem. Inf. Model..
[54] Charles L. Brooks,et al. Community-wide assessment of GPCR structure modelling and ligand docking: GPCR Dock 2008 , 2009, Nature Reviews Drug Discovery.